Literature DB >> 6321582

Isoproterenol inhibition of isolated human neutrophil function.

W W Busse, J M Sosman.   

Abstract

The human PMN can contribute to the inflammatory response. Several neutrophil responses can be inhibited by agonists that increase the cellular levels of cyclic AMP. In the following article, we compared the effects of ISO on lysosomal beta-glucuronidase release, superoxide generation, and CL in isolated human PMNs. ISO inhibited the neutrophil CL response to opsonized zymosan in a dose-dependent fashion with maximal effects at 10(-4)M. ISO inhibition of CL was not enhanced by the addition of theophylline, nor was CL inhibited by the exogenous addition cyclic AMP except at a very high concentration of 10(-3)M. ISO also suppressed beta-glucuronidase release and superoxide generation in neutrophils during an incubation with opsonized zymosan particles. For ISO to inhibit beta-glucuronidase release and superoxide generation, theophylline (5 X 10(-4)M) was necessary. ISO effectively inhibits three neutrophil functions that are capable of causing tissue inflammation. Although ISO suppressed all three neutrophil responses, the inhibitory mechanisms appear to be variable.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6321582     DOI: 10.1016/0091-6749(84)90416-0

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  12 in total

Review 1.  Is granulocyte or endothelial cell activation responsible for the initiation of granulocyte recruitment during acute inflammation?

Authors:  C J Whelan
Journal:  Agents Actions       Date:  1992-11

2.  Beta-adrenergic modulation of FMLP- and zymosan-induced intracellular and extracellular oxidant production by polymorphonuclear leukocytes.

Authors:  S Kopprasch; A Gatzweiler; J Graessler; H E Schröder
Journal:  Mol Cell Biochem       Date:  1997-03       Impact factor: 3.396

3.  Intracellular contents of cyclic nucleotides in neutrophils and lymphocytes from patients with systemic lupus erythematosus.

Authors:  M Shingu; K Tatsukawa; M Nobunaga
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

Review 4.  Beta 2 adrenergic receptors in asthma: a current perspective.

Authors:  T R Bai
Journal:  Lung       Date:  1992       Impact factor: 2.584

5.  Inhibition by salmeterol of increased vascular permeability and granulocyte accumulation in guinea-pig lung and skin.

Authors:  C J Whelan; M Johnson
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

6.  Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan-stimulated respiratory burst by 'type IV'-selective PDE inhibitors.

Authors:  G Dent; M A Giembycz; K F Rabe; P J Barnes
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

7.  Continuous and on demand use of bronchodilators in patients with non-steroid dependent asthma and chronic bronchitis: four-year follow-up randomized controlled study.

Authors:  C P van Schayck; E Dompeling; C L van Herwaarden; H Folgering; R P Akkermans; P J van den Broek; C van Weel
Journal:  Br J Gen Pract       Date:  1995-05       Impact factor: 5.386

8.  Perioperative changes in superoxide production in neonates and infants.

Authors:  K Mikawa; K Nishina; N Maekawa; H Yaku; H Obara; Y Uetani; H Nakamura
Journal:  Can J Anaesth       Date:  1993-12       Impact factor: 5.063

9.  Beta-adrenoceptor-mediated modulation of calcium ionophore activated polymorphonuclear leucocytes.

Authors:  J A Mack; C P Nielson; D L Stevens; R E Vestal
Journal:  Br J Pharmacol       Date:  1986-06       Impact factor: 8.739

10.  Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung.

Authors:  C J Whelan; M Johnson; C J Vardey
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.